GU Ventures portfolio company Sortina Pharma names Dione Kobayashi scientific advisor

• GU Ventures portfolio company Sortina Pharma appointed Dr. Dione Kobayashi as scientific adviser to support its next development phase.
• She will guide drug candidate selection and preclinical studies needed for a clinical trial application, focusing on glioblastoma.
• Sortina develops small-molecule sortilin inhibitors as oral treatments for hard-to-treat cancers.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GU Ventures AB published the original content used to generate this news brief on October 19, 2026, and is solely responsible for the information contained therein.